Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. [electronic resource]
- Journal of the science of food and agriculture May 2012
- 1441-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-0010
10.1002/jsfa.4723 doi
Animals Body Weight--drug effects Chemical and Drug Induced Liver Injury--drug therapy Cholesterol--blood Chronic Disease Disease Models, Animal Down-Regulation Liver--drug effects Liver Cirrhosis, Experimental--metabolism Male Matrix Metalloproteinases--metabolism Mice Mice, Inbred ICR Silybum marianum--chemistry Organ Size--drug effects Phytotherapy Plant Extracts--pharmacology Random Allocation Silymarin--pharmacology Thioacetamide Tissue Inhibitor of Metalloproteinases--metabolism Transcription Factor AP-1--metabolism Transforming Growth Factor beta1--metabolism Triglycerides--blood